“Clinical and Peripheral Blood Markers Predict Relapsed/Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant” (2025) Graduate Medical Scholars Journal, 1(S1). doi:10.1349/3143-6587.1.S1.14.